Cargando…
Prospective cardiovascular magnetic resonance imaging in adults with Alström syndrome: silent progression of diffuse interstitial fibrosis
BACKGROUND: Alström syndrome (ALMS) is a rare ciliopathy characterised by early onset insulin resistance, obesity, and dyslipidaemia and is a model for diseases that have huge social, health and economic impact. Cardiomyopathy develops in the majority, with high rates of morbidity and mortality, the...
Autores principales: | Baig, Shanat, Dowd, Rory, Edwards, Nicola C., Hodson, James, Fabritz, Larissa, Vijapurapu, Ravi, Liu, Boyang, Geberhiwot, Tarekegn, Steeds, Richard P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275389/ https://www.ncbi.nlm.nih.gov/pubmed/32503575 http://dx.doi.org/10.1186/s13023-020-01426-4 |
Ejemplares similares
-
Alström syndrome: a paradigm for diffuse fibrosis and clinical progression
por: Edwards, Nicola C, et al.
Publicado: (2013) -
Diffuse left ventricular interstitial fibrosis is associated with sub-clinical myocardial dysfunction in Alström Syndrome: an observational study
por: Edwards, Nicola C., et al.
Publicado: (2015) -
Treatment with PBI-4050 in patients with Alström syndrome: study protocol for a phase 2, single-Centre, single-arm, open-label trial
por: Baig, Shanat, et al.
Publicado: (2018) -
Diffuse Myocardial Interstitial Fibrosis and Dysfunction in Early Chronic Kidney Disease
por: Hayer, Manvir Kaur, et al.
Publicado: (2018) -
Relative Adipose Tissue Failure in Alström Syndrome Drives Obesity-Induced Insulin Resistance
por: Geberhiwot, Tarekegn, et al.
Publicado: (2021)